Cargando…
Selecting bioactive phenolic compounds as potential agents to inhibit proliferation and VEGF expression in human ovarian cancer cells
Ovarian cancer is a disease that continues to cause mortality in female individuals worldwide. Ovarian cancer is challenging to treat due to emerging resistance to chemotherapy, therefore, the identification of effective novel chemotherapeutic agents is important. Polyphenols have demonstrated poten...
Autores principales: | HE, ZHIPING, LI, BO, RANKIN, GARY O., ROJANASAKUL, YON, CHEN, YI CHARLIE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314987/ https://www.ncbi.nlm.nih.gov/pubmed/25663929 http://dx.doi.org/10.3892/ol.2014.2818 |
Ejemplares similares
-
Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells
por: HE, ZHIPING, et al.
Publicado: (2016) -
Theasaponin E(1) Inhibits Platinum-Resistant Ovarian Cancer Cells through Activating Apoptosis and Suppressing Angiogenesis
por: Li, Bo, et al.
Publicado: (2021) -
Gallic Acid Induces S and G2 Phase Arrest and Apoptosis in Human Ovarian Cancer Cells In Vitro
por: He, Zhiping, et al.
Publicado: (2021) -
Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway
por: HUANG, HAIZHI, et al.
Publicado: (2015) -
Theaflavin-3,3′-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells
por: Pan, Haibo, et al.
Publicado: (2018)